• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可吸入尺寸的 PLGA 微球增强了对重组结核分枝杆菌抗原 TB10.4-Ag85B 的体外 T 细胞反应。

PLGA microparticles in respirable sizes enhance an in vitro T cell response to recombinant Mycobacterium tuberculosis antigen TB10.4-Ag85B.

机构信息

Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599-7571, USA.

出版信息

Pharm Res. 2010 Feb;27(2):350-60. doi: 10.1007/s11095-009-0028-7. Epub 2009 Dec 19.

DOI:10.1007/s11095-009-0028-7
PMID:20024670
Abstract

PURPOSE

To study the use of poly (lactide-co-glycolide) (PLGA) microparticles in respirable sizes as carriers for recombinant tuberculosis (TB) antigen, TB10.4-Ag85B, with the ultimate goal of pulmonary delivery as vaccine for the prevention of TB.

MATERIALS AND METHODS

Recombinant TB antigens were purified from E. coli by FPLC and encapsulated into PLGA microparticles by emulsion/spray-drying. Spray-drying condition was optimized by half-factorial design. Microparticles encapsulating TB antigens were assessed for their ability to deliver antigens to macrophages for subsequent presentation by employing an in vitro antigen presentation assay specific to an Ag85B epitope.

RESULTS

Spray-drying condition was optimized to prepare PLGA microparticles suitable for pulmonary delivery (aerodynamic diameter of 3.3 microm). Antigen release from particles exhibited an initial burst release followed by sustained release up to 10 days. Antigens encapsulated into PLGA microparticles induced much stronger interleukin-2 secretion in a T-lymphocyte assay compared to antigen solutions for three particle formulations. Macrophages pulsed with PLGA-MDP-TB10.4-Ag85B demonstrated extended epitope presentation.

CONCLUSION

PLGA microparticles in respirable sizes were effective in delivering recombinant TB10.4-Ag85B in an immunologically relevant manner to macrophages. These results set the foundation for further investigation into the potential use of PLGA particles for pulmonary delivery of vaccines to prevent Mycobacterium tuberculosis infection.

摘要

目的

研究聚(乳酸-共-乙醇酸)(PLGA)亚微米颗粒作为重组结核(TB)抗原 TB10.4-Ag85B 的载体的用途,最终目标是通过肺部给药作为预防 TB 的疫苗。

材料和方法

从大肠杆菌中通过 FPLC 纯化重组 TB 抗原,并通过乳液/喷雾干燥将其包封在 PLGA 亚微米颗粒中。通过半因子设计优化喷雾干燥条件。通过体外抗原呈递测定评估包封 TB 抗原的微粒,该测定专门针对 Ag85B 表位,用于评估抗原向巨噬细胞递呈的能力。

结果

优化喷雾干燥条件以制备适合肺部给药的 PLGA 亚微米颗粒(空气动力学直径为 3.3 微米)。颗粒中的抗原释放表现出初始突释,随后持续释放长达 10 天。与三种颗粒制剂的抗原溶液相比,包封在 PLGA 微球中的抗原在 T 淋巴细胞测定中诱导更强的白细胞介素-2 分泌。用 PLGA-MDP-TB10.4-Ag85B 脉冲的巨噬细胞表现出延长的表位呈递。

结论

可吸入尺寸的 PLGA 微球能够以免疫相关的方式有效递呈重组 TB10.4-Ag85B 至巨噬细胞。这些结果为进一步研究 PLGA 颗粒在肺部递送来预防结核分枝杆菌感染的疫苗的潜在用途奠定了基础。

相似文献

1
PLGA microparticles in respirable sizes enhance an in vitro T cell response to recombinant Mycobacterium tuberculosis antigen TB10.4-Ag85B.可吸入尺寸的 PLGA 微球增强了对重组结核分枝杆菌抗原 TB10.4-Ag85B 的体外 T 细胞反应。
Pharm Res. 2010 Feb;27(2):350-60. doi: 10.1007/s11095-009-0028-7. Epub 2009 Dec 19.
2
Poly (lactide-co-glycolide) microspheres in respirable sizes enhance an in vitro T cell response to recombinant Mycobacterium tuberculosis antigen 85B.可吸入尺寸的聚(丙交酯-共-乙交酯)微球增强了体外T细胞对重组结核分枝杆菌抗原85B的反应。
Pharm Res. 2007 Oct;24(10):1834-43. doi: 10.1007/s11095-007-9302-8. Epub 2007 Jul 27.
3
Respirable PLGA microspheres containing rifampicin for the treatment of tuberculosis: manufacture and characterization.用于治疗结核病的含利福平的可吸入性聚乳酸-羟基乙酸共聚物微球:制备与表征
Pharm Res. 2000 Aug;17(8):955-61. doi: 10.1023/a:1007527204887.
4
Screening for potential adjuvants administered by the pulmonary route for tuberculosis vaccines.用于结核病疫苗的经肺途径给药潜在佐剂的筛选。
AAPS J. 2009 Mar;11(1):139-47. doi: 10.1208/s12248-009-9089-0. Epub 2009 Mar 10.
5
NGF release from poly(D,L-lactide-co-glycolide) microspheres. Effect of some formulation parameters on encapsulated NGF stability.聚(D,L-丙交酯-共-乙交酯)微球释放神经生长因子。某些制剂参数对包封的神经生长因子稳定性的影响。
J Control Release. 1998 Dec 4;56(1-3):175-87. doi: 10.1016/s0168-3659(98)00086-8.
6
Polymer degradation and in vitro release of a model protein from poly(D,L-lactide-co-glycolide) nano- and microparticles.聚(D,L-丙交酯-乙交酯)纳米和微粒的聚合物降解及模型蛋白的体外释放
J Control Release. 2003 Sep 19;92(1-2):173-87. doi: 10.1016/s0168-3659(03)00328-6.
7
Influence of suspension stabilisers on the delivery of protein-loaded porous poly (DL-lactide-co-glycolide) (PLGA) microparticles via pressurised metered dose inhaler (pMDI).混悬稳定剂对通过压力定量吸入器(pMDI)递送载蛋白多孔聚(DL-丙交酯-乙交酯)(PLGA)微粒的影响。
Pharm Res. 2014 Aug;31(8):2000-9. doi: 10.1007/s11095-014-1302-x. Epub 2014 Feb 19.
8
Intranasal vaccination with poly(lactide-co-glycolide) microparticles containing a peptide T of Ole e 1 prevents mice against sensitization.用含有Ole e 1肽T的聚(丙交酯-共-乙交酯)微粒进行鼻内接种可预防小鼠致敏。
Clin Exp Allergy. 2008 Mar;38(3):520-8. doi: 10.1111/j.1365-2222.2007.02922.x. Epub 2008 Jan 18.
9
Synthetic delivery system for tuberculosis vaccines: immunological evaluation of the M. tuberculosis 38 kDa protein entrapped in biodegradable PLG microparticles.用于结核病疫苗的合成递送系统:包裹于可生物降解聚乳酸-乙醇酸共聚物微粒中的结核分枝杆菌38 kDa蛋白的免疫学评估
Vaccine. 1995 Nov;13(16):1576-82. doi: 10.1016/0264-410x(95)00084-e.
10
Spray-dried chitosan microparticles for cellular delivery of an antigenic protein: physico-chemical properties and cellular uptake by dendritic cells and macrophages.喷雾干燥壳聚糖微球用于抗原蛋白的细胞递送:物理化学性质及树突状细胞和巨噬细胞的摄取。
Pharm Res. 2013 Jun;30(6):1677-97. doi: 10.1007/s11095-013-1014-7. Epub 2013 Mar 13.

引用本文的文献

1
Nanoparticle-Based Pulmonary Immune Engineering.基于纳米颗粒的肺部免疫工程
Annu Rev Chem Biomol Eng. 2025 Jun;16(1):249-270. doi: 10.1146/annurev-chembioeng-082223-105117. Epub 2025 Mar 12.
2
CFP10-loaded PLGA nanoparticles as a booster vaccine confer protective immunity against .负载CFP10的聚乳酸-羟基乙酸共聚物纳米颗粒作为加强疫苗可赋予针对……的保护性免疫。
Bioimpacts. 2022;12(5):395-404. doi: 10.34172/bi.2022.23645. Epub 2022 Jun 8.
3
Celecoxib Microparticles for Inhalation in COVID-19-Related Acute Respiratory Distress Syndrome.

本文引用的文献

1
Rational design of multiple TB antigens TB10.4 and TB10.4-Ag85B as subunit vaccine candidates against Mycobacterium tuberculosis.设计多个结核分枝杆菌抗原 TB10.4 和 TB10.4-Ag85B 作为针对结核分枝杆菌的亚单位疫苗候选物。
Pharm Res. 2010 Feb;27(2):224-34. doi: 10.1007/s11095-009-9995-y. Epub 2009 Oct 28.
2
Characterization and in vitro activities of cell-free antigens from Histoplasma capsulatum-loaded biodegradable microspheres.载有荚膜组织胞浆菌的生物可降解微球的无细胞抗原的特性和体外活性。
Eur J Pharm Sci. 2009 Dec 8;38(5):548-55. doi: 10.1016/j.ejps.2009.10.003. Epub 2009 Oct 13.
3
Spray drying technique. I: Hardware and process parameters.
用于新冠肺炎相关急性呼吸窘迫综合征吸入治疗的塞来昔布微粒
Pharmaceutics. 2022 Jun 30;14(7):1392. doi: 10.3390/pharmaceutics14071392.
4
Design of Polymeric Nanocapsules for Intranasal Vaccination against Mycobacterium Tuberculosis: Influence of the Polymeric Shell and Antigen Positioning.用于鼻内接种抗结核分枝杆菌疫苗的聚合物纳米胶囊设计:聚合物壳层和抗原定位的影响
Pharmaceutics. 2020 May 28;12(6):489. doi: 10.3390/pharmaceutics12060489.
5
Adjuvant Strategies for More Effective Tuberculosis Vaccine Immunity.提高结核病疫苗免疫效果的辅助策略
Microorganisms. 2019 Aug 12;7(8):255. doi: 10.3390/microorganisms7080255.
6
Single-dose Ag85B-ESAT6-loaded poly(lactic--glycolic acid) nanoparticles confer protective immunity against tuberculosis.载有 Ag85B-ESAT6 的单剂量聚乳酸-羟基乙酸纳米颗粒可提供针对结核病的保护性免疫。
Int J Nanomedicine. 2019 May 1;14:3129-3143. doi: 10.2147/IJN.S172391. eCollection 2019.
7
Nanoscale Peptide Self-assemblies Boost BCG-primed Cellular Immunity Against Mycobacterium tuberculosis.纳米级肽自组装物增强卡介苗接种诱导的针对结核分枝杆菌的细胞免疫。
Sci Rep. 2018 Aug 21;8(1):12519. doi: 10.1038/s41598-018-31089-y.
8
PLGA particulate subunit tuberculosis vaccines promote humoral and Th17 responses but do not enhance control of Mycobacterium tuberculosis infection.PLGA 颗粒亚单位结核疫苗可促进体液和 Th17 应答,但不能增强对结核分枝杆菌感染的控制。
PLoS One. 2018 Mar 19;13(3):e0194620. doi: 10.1371/journal.pone.0194620. eCollection 2018.
9
Potential of polymeric particles as future vaccine delivery systems/adjuvants for parenteral and non-parenteral immunization against tuberculosis: A systematic review.聚合物颗粒作为未来用于结核病肠胃外和非肠胃外免疫的疫苗递送系统/佐剂的潜力:一项系统综述。
Iran J Basic Med Sci. 2018 Feb;21(2):116-123. doi: 10.22038/IJBMS.2017.22059.5648.
10
Is There an Optimal Formulation and Delivery Strategy for Subunit Vaccines?亚单位疫苗是否存在最佳配方和递送策略?
Pharm Res. 2016 Sep;33(9):2078-97. doi: 10.1007/s11095-016-1979-0. Epub 2016 Jul 5.
喷雾干燥技术。I:硬件和工艺参数。
J Pharm Sci. 2010 Feb;99(2):575-86. doi: 10.1002/jps.21886.
4
Multivariate data analysis as a semi-quantitative tool for interpretive evaluation of comparability or equivalence of aerodynamic particle size distribution profiles.多元数据分析作为一种半定量工具,用于解释性评估空气动力学粒径分布曲线的可比性或等效性。
AAPS PharmSciTech. 2009;10(4):1113-20. doi: 10.1208/s12249-009-9303-5. Epub 2009 Sep 10.
5
Insulin-loaded microcapsules for in vivo delivery.用于体内递送的载胰岛素微胶囊。
Mol Pharm. 2009 Mar-Apr;6(2):353-65. doi: 10.1021/mp800087t.
6
The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.制剂变量对采用油中油单相溶剂蒸发法制备的载胰岛素聚(乳酸-乙醇酸共聚物)微球特性的影响。
Colloids Surf B Biointerfaces. 2009 Nov 1;74(1):340-9. doi: 10.1016/j.colsurfb.2009.08.003. Epub 2009 Aug 12.
7
Insulin nanoparticle preparation and encapsulation into poly(lactic-co-glycolic acid) microspheres by using an anhydrous system.通过无水体系制备胰岛素纳米颗粒并将其包封于聚乳酸-乙醇酸共聚物微球中。
Int J Pharm. 2009 Aug 13;378(1-2):159-66. doi: 10.1016/j.ijpharm.2009.05.021. Epub 2009 May 22.
8
Current advances in research and clinical applications of PLGA-based nanotechnology.基于聚乳酸-羟基乙酸共聚物(PLGA)的纳米技术在研究和临床应用方面的当前进展。
Expert Rev Mol Diagn. 2009 May;9(4):325-41. doi: 10.1586/erm.09.15.
9
Screening for potential adjuvants administered by the pulmonary route for tuberculosis vaccines.用于结核病疫苗的经肺途径给药潜在佐剂的筛选。
AAPS J. 2009 Mar;11(1):139-47. doi: 10.1208/s12248-009-9089-0. Epub 2009 Mar 10.
10
Defining macropinocytosis.界定巨吞饮作用。
Traffic. 2009 Apr;10(4):364-71. doi: 10.1111/j.1600-0854.2009.00878.x. Epub 2009 Jan 24.